COMMUNIQUÉS West-GlobeNewswire

Celularity Receives $12.2 Million from Sale of New Jersey Net Operating Losses
10/02/2026
FLORHAM PARK, N.J., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company, today announced receipt of $12.2 Million in net cash [...]
Oncotelic Therapeutics, Inc. Showcases Multi-Year Execution and Validation, Enters 2026 with Late-Stage Momentum Across Diversified Pipeline
10/02/2026
AGOURA HILLS, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- via IBN — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“Oncotelic” or the “Company”), a clinical-stage biopharmaceutical company focused on oncology, immunotherapy [...]
Septerna to Present Data from Phase 1 Clinical Trial of SEP-631 for the Treatment of Mast Cell-Driven Diseases at 2026 AAAAI Annual Meeting
10/02/2026
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today [...]
Imprivata Introduces Advanced Access Management and Passwordless Authentication Capabilities to Improve User Efficiency and Strengthen Security
10/02/2026
Tailored for all users and workflows, Imprivata Enterprise Access Management now offers context-aware passwordless authentication, advanced biometrics, and AI-powered behavioral analytics to further streamline access to [...]
Health Canada cannabis guidance exposes “absurd” education gap in healthcare
10/02/2026
- Apothecare calls for medical cannabis education to be integrated into clinical training and standard practice, not left to patients to figure out on their own - TORONTO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- New federal [...]
TerrAscend to Host Fourth Quarter and Full Year 2025 Earnings Conference Call
10/02/2026
TORONTO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF) , a leading North American cannabis company, today announced that it will host a scheduled [...]
VirtuAlly Among First in Nation to Deliver Specialized Virtual Nursing in Neonatal Intensive Care Setting
10/02/2026
Partnership with MUSC brings virtual nursing to South Carolina’s highest-acuity NICU. CHARLESTON, S.C., Feb. 10, 2026 (GLOBE NEWSWIRE) -- VirtuAlly , a national leader in virtual nursing (VRN) and clinical support [...]
Practicing Excellence Acquires Sageful AI to Accelerate Scalable Behavior Change Across Healthcare
10/02/2026
Combined organization strengthens personalized, in-workflow coaching aligned to organizational priorities SAN DIEGO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Practicing Excellence , the leading platform for technology-powered [...]
Survey Reveals the Hidden Mental & Social Burden of Managing Celiac Disease
10/02/2026
More than half of people with celiac say they feel isolated or excluded; a majority admit they avoid restaurants and family gatherings just to prevent accidental gluten exposure BOSTON, Feb. 10, 2026 (GLOBE NEWSWIRE [...]
Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026
10/02/2026
BRISBANE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for [...]
Milestone Pharmaceuticals Appoints David Sandoval as General Counsel and Chief Compliance Officer
10/02/2026
New appointment strengthens executive leadership commensurate with launch of CARDAMYST™ (etripamil) nasal spray MONTREAL and CHARLOTTE, N.C., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: [...]
Codexis Achieves ISO 9001:2015 Certification
10/02/2026
REDWOOD CITY, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Codexis Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, announced today that it has earned [...]
INmune Bio Advances CORDStrom™ Towards UK Marketing Authorization in RDEB
10/02/2026
Pre-submission package is a process that facilitates early feedback from the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA), designed to streamline the final approval process and reduce [...]
Zhengye Biotechnology Holding Limited Issues 2026 Chairman’s Letter to Shareholders
10/02/2026
Jilin, China, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing [...]
Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™
10/02/2026
Oral presentation highlighted the effect of gemfibrozil on Krabbe disease, one of four LSDs in the upcoming Phase 2 SOTERIA basket trial evaluating PLX-200 (reformulated gemfibrozil) PARAMUS, NJ, Feb. 10, 2026 (GLOBE [...]
Transdermal GFR Article Recognized as One of Five 2025 Editors’ Choice Articles by Journal of the American Society of Nephology (JASN)
10/02/2026
MediBeacon ® Transdermal GFR System is a first-in-kind product for point of care kidney function assessment Centers of Excellence commercialization in select academic medical centers began in January 2026 ST. LOUIS, Feb [...]
Spectral AI Names Vincent S. Capone as Chief Executive Officer
10/02/2026
DALLAS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]
Krystal Biotech to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
10/02/2026
PITTSBURGH, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that it will report its fourth quarter and full year 2025 financial results on Tuesday, February 17, [...]
Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies
10/02/2026
Financing led by Investissement Qu é bec with continued support from long-standing investors Plans include the acceleration of clinical development of breakthrough GPCR targeting treatments for patients MONTREAL and [...]

Pages